Skip to main content

Antioxidant

Calebin-A (CurCousin®)

Also known as: Calebin A, 4-Methylcurcumin, curcumin derivative

C
Evidence

A proprietary curcumin analog (98% Calebin-A) derived from turmeric with enhanced bioavailability and potential metabolic properties distinct from standard curcumin. An emerging derivative researched for inflammation and cellular health.

Primary uses

  • Antioxidant support
  • Inflammation modulation
  • Cellular health
  • Metabolic support

How it works

  • NF-κB pathway inhibition
  • Antioxidant/free radical scavenging
  • Mitochondrial function support
  • Microsomal stability (superior to standard curcumin)

Dosage

Typical range
150-400 mg daily
Timing
With meals and fat sources
With food
Essential; fat-soluble and requires dietary lipids for absorption
Duration
Continuous use recommended; effects typically develop over 4-12 weeks
Special populations
Pregnancy/nursing: avoid; gallbladder disease: consult provider; anticoagulant users: monitor

Forms

  • 98% Calebin-A standardized extract· 70/100

Safety

Common side effects

  • Gastrointestinal upset (mild)
  • Staining of teeth or tongue (turmeric-related)

Contraindications

  • Pregnancy and breastfeeding
  • Biliary obstruction or severe gallbladder disease
  • High-dose use with anticoagulants

Evidence notes

Preliminary and emerging data on Calebin-A; in vitro and animal studies show promise; very limited human clinical trial data compared to standard curcumin; bioavailability advantage over curcumin is proposed but human evidence is sparse.

Grade C: Mostly observational or small trials; mechanism is plausible but unproven at scale.

Related in Antioxidant

Check a full stack

Formulate's free interaction checker lets you paste in any combination of supplements and medications at once — every pairing flags severity, timing, and cited evidence.

Open the checker

Medical disclaimer. This page is educational and does not replace advice from a qualified healthcare provider.